losartan/hydrochlorothiazide stada 50 mg/12,5 mg apvalkotās tabletes
stada arzneimittel ag, germany - losartanum kalicum, hydrochlorothiazidum - apvalkotā tablete - 50 mg/12,5 mg
losartan/hydrochlorothiazide stada 100 mg/12,5 mg apvalkotās tabletes
stada arzneimittel ag, germany - losartanum kalicum, hydrochlorothiazidum - apvalkotā tablete - 100 mg/12,5 mg
losartan/hydrochlorothiazide stada 100 mg/25 mg apvalkotās tabletes
stada arzneimittel ag, germany - losartanum kalicum, hydrochlorothiazidum - apvalkotā tablete - 100 mg/25 mg
tegsedi
akcea therapeutics ireland limited - inotersen nātrija - amiloidoze - other nervous system drugs - Ārstniecības posma 1. vai 2. posms polineiropātijas pieaugušo pacientiem ar iedzimtu transthyretin amiloidozi (hattr).
onpattro
alnylam netherlands b.v. - patisiran nātrija - amiloidozi, Ģimenes - other nervous system drugs - onpattro ir indicēts, lai ārstētu iedzimtu transthyretin starpniecību amiloidozi (hattr amiloidozi) pieaugušiem pacientiem ar 1. posms 2. posma polineiropātijas.
vyndaqel
pfizer europe ma eeig - tafamidis - amiloidoze - other nervous system drugs - vyndaqel tiek norādīts transthyretin amyloidosis pieaugušiem pacientiem ar 1. posms simptomātiska polineiropātijas aizkavēt perifērijas neiroloģisku traucējumu ārstēšanai.
benamax flavour
lavet pharmaceuticals ltd., ungārija - benazepril hidrohlorīds - tabletes - 20 mg - suņi
benamax flavour
lavet pharmaceuticals ltd., ungārija - benazepril hidrohlorīds - tabletes - 5 mg - suņi
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiski līdzekļi - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.
amvuttra
alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - other nervous system drugs - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.